Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats

Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus

(2011) EM Rock et al.   BRITISH JOURNAL OF PHARMACOLOGY

Time-dependent in-vivo effects of interleukin-2 on neurotransmitters in various cortices: Relationships with depressive-related and anxiety-like behaviour

(2011) B.D. Karrenbauer et al.   JOURNAL OF NEUROIMMUNOLOGY

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour

(2011) Serena Deiana et al.   PSYCHOPHARMACOLOGY

Anxiogenic-like effects of chronic cannabidiol administration in rats

(2011) Maha M. ElBatsh et al.   PSYCHOPHARMACOLOGY

Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors

(2010) Vanessa de Paula Soares et al.   BEHAVIOURAL BRAIN RESEARCH

Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors

(2010) Plinio C. Casarotto et al.   BEHAVIOURAL PHARMACOLOGY

The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors

(2010) Felipe V. Gomes et al.   PSYCHOPHARMACOLOGY

Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice

(2010) Tommaso Cassano et al.   PSYCHOPHARMACOLOGY

Acute and chronic effects of citalopram on 5-HT1A receptor-Labeling by [18F]MPPF and-Coupling to receptors-G proteins

(2010) Marcelle Moulin-Sallanon et al.   SYNAPSE

Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

(2009) Paolo Fusar-Poli et al.   ARCHIVES OF GENERAL PSYCHIATRY

Extracellular serotonin level in the basolateral nucleus of the amygdala and dorsal periaqueductal gray under unconditioned and conditioned fear states: An in vivo microdialysis study

(2009) Janaina M. Zanoveli et al.   BRAIN RESEARCH

Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress

(2009) Francis Rodriguez Bambico et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine

(2009) Janaina M. Zanoveli et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Long-Term Fluoxetine Treatment Modulates Cannabinoid Type 1 Receptor-Mediated Inhibition of Adenylyl Cyclase in the Rat Prefrontal Cortex through 5-Hydroxytryptamine1A Receptor-Dependent Mechanisms

(2009) S. Mato et al.   MOLECULAR PHARMACOLOGY

Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission

(2009) Francis Rodriguez Bambico et al.   NEUROBIOLOGY OF DISEASE

Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids

(2009) Alline Cristina Campos et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Dopaminergic and serotonergic activity in neostriatum and nucleus accumbens enhanced by intranasal administration of testosterone

(2008) M.A. de Souza Silva et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze

(2008) SN Pinheiro et al.   JOURNAL OF PSYCHOPHARMACOLOGY

WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality

(2008) Elena Castro et al.   NEUROPHARMACOLOGY

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

(2008) Alline Cristina Campos et al.   PSYCHOPHARMACOLOGY

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

(2007) A Thomas et al.   BRITISH JOURNAL OF PHARMACOLOGY